Veterinary Medicines

Promycine Pulvis 4800 IU/mg Poeder voor toediening in het drinkwater/in de melk

Authorised
  • COLISTIN SULFATE
Download as PDF

Product identification

Medicine name:
Promycine Pulvis 4800 IU/mg Poeder voor toediening in het drinkwater/in de melk
Promycine Pulvis 4800 IU/mg Poudre pour administration dans le lait ou l'eau de boisson
Promycine Pulvis 4800 IU/mg Pulver zum Eingeben über das Trinkwasser/die Milch
Active substance:
  • COLISTIN SULFATE
Target species:
  • Pig
  • Chicken
  • Cattle (calf)
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • COLISTIN SULFATE
    4800000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water/milk
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Pig
      • Meat and offal
        2
        day
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Promycine Pulvis 2 kg Bag Powder for use in drinking water/milk
  • Promycine Pulvis 1 kg Bag Powder for use in drinking water/milk
  • Promycine Pulvis 500 g Bag Powder for use in drinking water/milk
  • Promycine Pulvis 250 g Bag Powder for use in drinking water/milk
  • Promycine Pulvis 100 g Bag Powder for use in drinking water/milk
  • Promycine Pulvis 2 kg Jar Powder for use in drinking water/milk
  • Promycine Pulvis 1 kg Jar Powder for use in drinking water/milk
  • Promycine Pulvis 500 g Jar Powder for use in drinking water/milk
  • Promycine Pulvis 250 g Jar Powder for use in drinking water/milk
  • Promycine Pulvis 100 g Jar Powder for use in drinking water/milk

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • VMD N.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download